EP.17A.01 The Cumulative Incidence of Brain Metastases in US Medicare Patients with ALK+ mNSCLC Treated with Second-generation ALK TKIs

Autor:	Bazhenova, L., Abrahami, D., Ramaswamy, K., Li, B., Davis, M., Epstein, A.J., Marcum, Z.A., Rifi, N., Kelton, J., Duncan, K., Uprety, D.
Zdroj:	In Journal of Thoracic Oncology October 2024 19(10) Supplement:S711-S712
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu